Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of TAK-379 in Type 2 Diabetes
NCT00722917Phase 2Terminated
- Sponsor
- Takeda
- Start
- Jul 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TAK-379 in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jul 2008; status: terminated.
02
Drugs
TAK-379
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00722917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00722917.